丨证券研究报告丨 公司研究丨点评报告丨华致酒行（300755.SZ） [Table_Title] 华致酒行 2024 年报点评：业绩有所承压， 静待需求回暖 报告要点 [Table_Summary] 公司发布 2024 年报，2024 年实现营收 94.6 亿元，同比下滑 6.5%，实现归母净利润 4445 万 元，同比下滑 81.1%。单四季度，实现营收 16.3 亿元，同比下滑 12.6%，归母净亏损 1.2 亿 元，去年同期为盈利 435 万元。 分析师及联系人 [Table_Author] SAC：S0490514080004 SAC：S0490520080019 SFC：BUV258 李锦 罗祎 张彦淳 请阅读最后评级说明和重要声明 %% %% %% %% research.95579.com 1 华致酒行（300755.SZ） cjzqdt11111 [Table_Title 华致酒行 2024 2] 年报点评：业绩有所承压，静待 需求回暖 [Table_Summary2] 事件描述 公司发布 2024 年报，2024 年实现营收 94.6 亿元，同比下滑 6.5%，实现归母净利润 4445 万 ...

丨证券研究报告丨 公司研究丨点评报告丨荣泰健康（603579.SH） [Table_Title] 业绩阶段性回落，积极拓展增量 荣泰健康（603579.SH） cjzqdt11111 报告要点 [Table_Summary] 2024 年全年公司实现营收 15.97 亿元，同比-13.92%，实现归母净利润 1.92 亿元，同比-5.31%， 实现扣非归母净利润 1.63 亿元，同比-12.47%；其中，2024Q4 公司实现营收 4.33 亿元，同比 -22.34%，实现归母净利润 0.49 亿元，同比-3.02%，实现扣非归母净利润 0.36 亿元，同比- 30.28%。2025 Q1 公司实现营收 3.95 亿元，同比-1.41%，实现归母净利润 0.44 亿元，同比- 29.97%，实现扣非归母净利润 0.32 亿元，同比-46.83%。 分析师及联系人 [Table_Author] 陈亮 SAC：S0490517070017 SFC：BUW408 请阅读最后评级说明和重要声明 %% %% %% %% research.95579.com 1 [Table_Title2] 业绩阶段性回落，积极拓展增量 ...

证券研究报告·公司点评报告·通用设备 | [Table_EPS] 盈利预测与估值 | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业总收入（百万元） | 2,660 | 2,589 | 2,745 | 3,198 | 3,736 | | 同比（%） | (1.35) | (2.67) | 6.01 | 16.51 | 16.82 | | 归母净利润（百万元） | 395.50 | 293.52 | 299.52 | 343.05 | 399.60 | | 同比（%） | (4.44) | (25.78) | 2.04 | 14.54 | 16.48 | | EPS-最新摊薄（元/股） | 0.60 | 0.45 | 0.45 | 0.52 | 0.61 | | P/E（现价&最新摊薄） | 24.75 | 33.34 | 32.68 | 28.53 | 24.49 | [Table_Tag] [投资要点 Table_Summary] ◼ 业绩短期承压，海外业务进展顺利 分产品看：齿轮减速机实现 ...

证券研究报告·公司点评报告·电网设备 起帆电缆（605222） 2024 年报及 2025 年一季报点评：营收业绩 短期承压，海缆增长等候时机 买入（维持） | [Table_EPS] 盈利预测与估值 | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业总收入（百万元） | 23,348 | 22,764 | 21,161 | 22,839 | 23,545 | | 同比（%） | 13.10 | (2.50) | (7.04) | 7.93 | 3.09 | | 归母净利润（百万元） | 423.19 | 135.50 | 286.26 | 371.51 | 451.16 | | 同比（%） | 15.42 | (67.98) | 111.26 | 29.78 | 21.44 | | EPS-最新摊薄（元/股） | 1.02 | 0.33 | 0.69 | 0.90 | 1.09 | | P/E（现价&最新摊薄） | 14.30 | 44.67 | 21.15 | 16.29 | 13.42 ...

证券研究报告·公司点评报告·自动化设备 伟创电气（688698） 2025 年一季报点评：业绩符合预期，战略布 局"机器人+数字能源"业务 买入（维持） | [Table_EPS] 盈利预测与估值 | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业总收入（百万元） | 1,305 | 1,640 | 1,993 | 2,403 | 2,897 | | 同比（%） | 44.03 | 25.70 | 21.48 | 20.62 | 20.56 | | 归母净利润（百万元） | 190.80 | 245.03 | 306.21 | 379.12 | 459.08 | | 同比（%） | 36.38 | 28.42 | 24.97 | 23.81 | 21.09 | | EPS-最新摊薄（元/股） | 0.90 | 1.16 | 1.45 | 1.79 | 2.17 | | P/E（现价&最新摊薄） | 53.38 | 41.56 | 33.26 | 26.86 | 22.18 | [Table_T ...

证券研究报告·公司点评报告·能源金属 盛新锂能（002240） 买入（维持） | [Table_EPS] 盈利预测与估值 | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业总收入（百万元） | 7,951 | 4,581 | 4,840 | 6,660 | 8,435 | | 同比（%） | (33.96) | (42.38) | 5.64 | 37.62 | 26.64 | | 归母净利润（百万元） | 702.24 | (621.58) | (152.06) | 357.73 | 900.16 | | 同比（%） | (87.35) | (188.51) | 75.54 | 335.26 | 151.63 | | EPS-最新摊薄（元/股） | 0.77 | (0.68) | (0.17) | 0.39 | 0.98 | | P/E（现价&最新摊薄） | 14.60 | (16.49) | (67.42) | 28.66 | 11.39 | [Table_Tag] [Table_Summa ...

Investment Rating - The report maintains a "Buy" rating for the company [1]. Core Insights - The company reported a strong performance in Q1 2025, with operating income of 18.495 billion, a year-on-year increase of 5.6%, and a net profit attributable to shareholders of 7.417 billion, up 5.8% year-on-year [4][5]. - The annualized weighted average return on equity (ROE) was 14.18%, a decrease of 1.33 percentage points year-on-year [4]. Financial Performance - Q1 revenue and profit growth rates were both above 5%, indicating strong resilience in the fundamentals. The year-on-year growth rates for revenue, pre-provision operating profit (PPOP), and net profit attributable to shareholders were 5.6%, 10%, and 5.8%, respectively [5]. - The net interest income and non-interest income growth rates were 11.6% and -5.8%, respectively, compared to the previous year [5]. - The loan growth rate was over 20%, with a significant increase in loans to corporate clients, which accounted for nearly 86% of new loans in Q1 [6]. Asset Quality - The non-performing loan (NPL) ratio remained stable at 0.76%, with a coverage ratio of 370.5% [10]. - The company increased its credit impairment losses in Q1 to 4.94 billion, up 10.3% year-on-year [10]. Capital Adequacy - The core Tier 1 capital ratio, Tier 1 capital ratio, and total capital ratio were 9.32%, 10.44%, and 14.94%, respectively, all showing a decline compared to the previous year [10]. Earnings Forecast and Valuation - The company aims to maintain stable profitability, with EPS forecasts for 2025, 2026, and 2027 at 4.44, 4.82, and 5.27 yuan, respectively. The current stock price corresponds to a price-to-book (PB) ratio of 0.71, 0.64, and 0.58 for the respective years [11][12].

Investment Rating - The report maintains a "Buy" rating for the company [1]. Core Views - The company reported better-than-expected performance in Q4 2024, with a focus on optimizing the supply chain for its plant protection business [5][6]. - The company's revenue for 2024 was 5.68 billion yuan, a decrease of 11.88% year-on-year, but it achieved a net profit of 103 million yuan, marking a return to profitability [5][6]. - The plant protection business experienced a revenue decline due to falling pesticide prices, but gross margins improved due to technological innovation and management optimization [6][7]. - The company is expanding its supply chain layout with a new production base in Malaysia, enhancing its service offerings across the product lifecycle [7]. Summary by Sections Financial Performance - In Q4 2024, the company achieved a revenue of 1.32 billion yuan, down 7.44% year-on-year, but net profit reached 70.64 million yuan, a significant increase of 285% quarter-on-quarter [5]. - For Q1 2025, revenue was 1.51 billion yuan, up 3.02% year-on-year and 14.55% quarter-on-quarter, with a net profit of 49.72 million yuan, reflecting a year-on-year growth of 1747% [5]. Business Segments - The pharmaceutical segment generated 1.29 billion yuan in revenue, down 13.3% year-on-year, but gross margin improved by 13.1 percentage points to 48.0% [6]. - The plant protection segment had a revenue of 3.59 billion yuan, down 15.4% year-on-year, with a gross margin increase of 5.8 percentage points to 20.1% [6]. Future Outlook - The company has revised its profit forecasts for 2025-2027, expecting net profits of 305 million yuan, 415 million yuan, and 536 million yuan respectively, reflecting a positive outlook based on industry recovery and improved margins [8][9]. - The report highlights the company's ongoing projects in the pharmaceutical sector, including six validation projects, with a focus on API and innovative drug intermediates [7][8].

2025 年 4 月 29 日 公司研究 收入利润实现高增长，盈利能力及经营质量同比改善 ——麦加芯彩（603062.SH）2025 年一季报点评 要点 事件：麦加芯彩发布 2025 年一季报。25Q1，公司实现收入/归母净利润/扣非归 母净利润 4.2/0.50/0.46 亿元，同比+41%/+77%/+105%。 点评： 集装箱涂料同比高增受益于低基数，风电涂料同比高增受益于下游高景气度。 25Q1，公司集装箱涂料/风电涂料/其他工业涂料收入分别为 3.1/1.1/0.01 亿元， 同比+41%/+47%/-83%，其中销量分别为 19006/3617/46 吨，同比 +29%/+67%/-84%，均价分别为 1.6/3.2/2.1 万元/吨，同比+10%/-12%/+8%。 25Q1，集装箱涂料业务收入及销量高增长主要受益于低基数，24 年集装箱涂料 景气度前低后高；风电涂料业务收入及销量高增长主要受益于下游风电行业高景 气度。 投资建议：25Q1，麦加芯彩收入利润均实现较快增长，主要受益于低基数效应 以及下游风电行业高景气度。24 年至今公司在新业务拓展方面取得了较多实质 性进展：风电涂料海外市场取得 ...

24 年收入增速+11.7%，维持"买入"评级 24 年全年实现营收/归母净利润 63.27/3.19 亿元，同比+11.66%/-18.65%， 全年实现扣非归母净利润 2.83 亿元，同比-19.17%。其中 Q4 单季度实现收 入 13.38 亿元，同比-13.53%，归母净利润/扣非归母净利润 0.09/-0.06 亿元， 同比-90.35%/-107.82%。在 24 年耐火材料行业整体运行偏弱、行业企业盈 利普遍下滑的背景下，公司总体运行平稳，展现出较好的韧性。考虑到下 游钢铁行业价格仍处在较为底部区间，下调公司 25-27 年归母净利润分别 为 3.3/3.8/4.6 亿（25-26 年前值为 5.9/6.8 亿），维持"买入"评级。 公司报告 | 年报点评报告 北京利尔（002392） 证券研究报告 行业偏弱运行，公司经营仍显韧性 各板块收入持续增加，其中原材料销售增长明显 分行业来看，耐火材料/其他（冶金炉料为主）业务收入分别为 44.7/18.6 亿，同比+1.3%/+48.3%。耐火材料中，整体承包/直销收入分别为 38.6/6.1 亿元，同比-1.2%/+20.4%，耐火材料直销中原料 ...